Phase I/IIa trial evaluates prime-boost vaccination with AdCh63-MSP1 and MVA-MSP1 malaria vaccines Nov. 15, 2010
V-211 vaccine reduces incidence of shingles in adults aged 50-59 years in phase III trial Nov. 11, 2010
RSS